𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of hepatocellular carcinoma in the waiting list before liver transplantation

✍ Scribed by Pietro Majno; Emiliano Giostra; Philippe Morel; Antoine Hadengue; Gilles Mentha; for the Geneva Liver Cancer Study Group

Book ID
116650603
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
180 KB
Volume
42
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Management of hepatocellular carcinoma o
Management of hepatocellular carcinoma on the waiting list before liver transplantation: Time for controlled trials?
✍ Pietro Majno; Emiliano Giostra; Gilles Mentha πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB

Francisco; RFTA, radiofrequency thermal ablation; TACE, transarterial chemoembolization; UNOS, United Network for Organ Sharing. This article is based on a review of the treatment of hepatocellular carcinoma while patients are on a liver transplant waiting list that our group published in Journal of

Transplantation for hepatocellular carci
Transplantation for hepatocellular carcinoma: Management of patients on the waiting list
✍ Pietro Majno; Gilles Mentha; Christian Toso; for the Geneva Liver Cancer Study G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

In discussing the mananagement of patients in the waiting list, the terms neoadjuvant treatment, bridging, downstaging and dropout should be used consistently, and on the basis of accepted selection criteria (currently MC, incorporated into the tumor-nodemetastasis [TNM] staging system as follows: T

Tools for monitoring patients with hepat
Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation
✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de SantibaΓ±ez; Michael Kew πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i